Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms

B-type natriuretic peptide (BNP) is an endogenous peptide produced under physiological and pathological conditions mainly by ventricular myocytes. It has natriuretic, diuretic, blood pressure-lowering, and antifibrotic actions that could mediate cardiorenal protection in cardiovascular diseases. In...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation. Heart failure 2011-07, Vol.4 (4), p.483-495
Hauptverfasser: Moilanen, Anne-Mari, Rysä, Jaana, Mustonen, Erja, Serpi, Raisa, Aro, Jani, Tokola, Heikki, Leskinen, Hanna, Manninen, Aki, Levijoki, Jouko, Vuolteenaho, Olli, Ruskoaho, Heikki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:B-type natriuretic peptide (BNP) is an endogenous peptide produced under physiological and pathological conditions mainly by ventricular myocytes. It has natriuretic, diuretic, blood pressure-lowering, and antifibrotic actions that could mediate cardiorenal protection in cardiovascular diseases. In the present study, we used BNP gene transfer to examine functional and structural effects of BNP on left ventricular (LV) remodeling. Human BNP was overexpressed by using adenovirus-mediated gene delivery in normal rat hearts and in hearts during the remodeling process after infarction and in an experimental model of angiotensin II-mediated hypertension. In healthy hearts, BNP gene delivery into the anterior wall of the LV decreased myocardial fibrosis (P
ISSN:1941-3289
1941-3297
DOI:10.1161/CIRCHEARTFAILURE.110.958033